An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Age-related macular degeneration (AMD) is one of the leading causes of vision ... There are two main types: dry (atrophic) AMD and wet (neovascular) AMD. Dry AMD is more common, accounting for about ...

The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

Presenters at a myth breakers session at the American Academy of Ophthalmology took aim at some prevailing notions.

CHICAGO, CA, UNITED STATES, October 18, 2024 /EINPresswire / -- The Global Age-Related Macular Degeneration (AMD) <a target=_blank href= ...

Visgenx, a retinal gene therapy Company Presentation will discuss the Company's gene therapy (VGX-0111) with a <a target=_blank href= ...

According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...

Dr. Eric Guglielmo, above, recently joined Dr. Frank Venzara III and Dr. Timothy Tweito in the busy Florida Retina Specialists practice with offices in Merritt Island and Viera.

injection for the treatment of neovascular or wet age-related macular degeneration (wet AMD). Ixo-vec is currently being evaluated in the Phase 2 LUNA clinical trial. The company plans to announce ...